Nanomaterials,
Journal Year:
2024,
Volume and Issue:
14(5), P. 389 - 389
Published: Feb. 20, 2024
Disordered
reactive
oxygen/nitrogen
species
are
a
common
occurrence
in
various
diseases,
which
usually
cause
cellular
oxidative
damage
and
inflammation.
Despite
the
wide
range
of
applications
for
biomimetic
nanoparticles
with
antioxidant
or
anti-inflammatory
properties,
designs
that
seamlessly
integrate
these
two
abilities
synergistic
effect
simple
manner
seldom
reported.
In
this
study,
we
developed
novel
PEI-Mn
composite
nanoparticle
(PM
NP)
using
chelation
method,
curcumin
was
loaded
onto
PM
NPs
via
metal–phenol
coordination
to
form
PEI-Mn@curcumin
(PMC
NPs).
PMC
possessed
excellent
dispersibility
cytocompatibility,
engineered
serve
as
an
effective
nanozyme,
exhibited
specific
SOD-like
CAT-like
activities.
addition,
incorporation
granted
ability
effectively
suppress
expression
inflammatory
cytokines
microglia
induced
by
LPS.
As
also
has
it
further
amplified
efficiency
ROS
scavenging.
Significantly,
scavenged
triggered
H2O2
SIM-A9
cells
Neuro-2a
cells.
considerably
mitigated
DNA
lipid
oxidation
demonstrated
increase
cell
viability
under
concentrations.
These
properties
suggest
have
significant
potential
addressing
excessive
inflammation
related
neural
diseases.
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(8), P. 2081 - 2081
Published: Aug. 3, 2023
Brain-derived
neurotrophic
factor
(BDNF)
is
a
neurotrophin
that
plays
significant
role
in
the
survival
and
development
of
neurons,
being
involved
several
diseases
such
as
Alzheimer’s
disease
major
depression
disorder.
The
association
between
BDNF
depressive
disorder
subject
extensive
research.
Indeed,
numerous
studies
indicate
decreased
levels
are
linked
to
an
increased
occurrence
symptoms,
neuronal
loss,
cortical
atrophy.
Moreover,
it
has
been
observed
antidepressive
therapy
can
help
restore
levels.
In
this
review,
we
will
focus
on
serotonergic
imbalance
associated
stress
conditions,
particularly
hypothalamic–pituitary–adrenal
(HPA)
axis
dysregulation
oxidative
stress.
All
these
features
highly
connected
signaling
pathways
context
disease,
exploring
topic
aim
advance
our
understanding
disorder,
improve
diagnostic
treatment
approaches,
potentially
identify
new
therapeutic
targets
alleviate
heavy
burden
society.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(3), P. 574 - 574
Published: March 5, 2024
Neurodegeneration
poses
a
significant
challenge
for
the
fields
of
neuroscience
and
medicine,
as
it
is
underlying
cause
development
advancement
numerous
neurodegenerative
psychiatric
disorders
[...]
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(16), P. 8675 - 8675
Published: Aug. 8, 2024
Omega-3
polyunsaturated
fatty
acids
have
received
considerable
attention
in
the
field
of
mental
health,
particular
regarding
treatment
depression.
This
review
presents
an
overview
current
research
on
role
omega-3
prevention
and
depressive
disorders.
The
existing
body
evidence
demonstrates
that
acids,
eicosapentaenoic
acid
(EPA)
docosahexaenoic
(DHA),
antidepressant
effects
can
be
attributed
to
their
modulation
neuroinflammation,
neurotransmitter
function,
neuroplasticity.
Nevertheless,
clinical
trials
supplementation
yielded
inconsistent
results.
Some
studies
demonstrated
significant
reductions
symptoms
following
treatment,
whereas
others
shown
minimal
no
beneficial
impact.
A
range
factors,
encompassing
dosage,
ratio
EPA
DHA,
baseline
nutritional
status,
been
identified
as
having
a
potential
impact
noted
Furthermore,
it
has
suggested
may
act
adjunctive
for
those
undergoing
treatment.
Notwithstanding
these
encouraging
findings,
discrepancies
study
designs
variability
individual
responses
underscore
necessity
further
order
establish
uniform,
standardized
guidelines
use
management
Open Medicine,
Journal Year:
2025,
Volume and Issue:
20(1)
Published: Jan. 1, 2025
Diabetes-related
cognitive
impairment
is
increasingly
recognized
as
a
significant
complication,
profoundly
impacting
patients'
quality
of
life.
This
review
aims
to
examine
the
pathophysiological
mechanisms,
clinical
manifestations,
risk
factors,
assessment
and
diagnosis,
management
strategies,
future
research
directions
in
diabetes.
A
comprehensive
literature
search
was
conducted
using
PubMed,
Medline,
other
medical
databases
identify,
review,
evaluate
published
articles
on
The
focused
studies
examining
pathophysiology,
presentations,
diagnostic
approaches,
strategies.
current
revealed
that
chronic
hyperglycemia,
insulin
resistance,
vascular
factors
are
major
contributing
deficits
Clinical
manifestations
include
impairments
attention,
memory,
executive
function,
visuospatial
abilities,
language.
Risk
encompass
disease
duration,
glycemic
control,
presence
complications,
age,
education
level,
comorbidities.
Assessment
tools
screening
instruments,
neuropsychological
testing,
neuroimaging
techniques.
Management
strategies
involve
control
optimization,
lifestyle
modifications,
training,
pharmacological
interventions.
highlights
prevalence
impact
diabetes,
resulting
from
complex
metabolic
disturbances.
Early
detection
multifaceted
interventions
crucial
for
preserving
function
improving
patient
outcomes.
Future
should
focus
neuroprotective
biomarker
identification,
personalized
approaches.
Collaborative
efforts
between
clinicians
researchers
essential
effectively
address
this
growing
healthcare
challenge
enhance
life
individuals
with
diabetes-related
impairment.
Advanced Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 21, 2025
Abstract
Depression
is
a
common
psychiatric
disorder,
and
monoamine‐based
antidepressants
as
first‐line
therapy
remain
ineffective
in
some
patients.
The
synergistic
modulation
of
neuroinflammation
neuroplasticity
could
be
major
strategy
for
treating
depression.
In
this
study,
an
inflammation‐targeted
microglial
biomimetic
system,
PDA‐Mem@M,
reported
Microglial
membrane‐coated
nanoparticles
penetrate
the
blood‐brain
barrier
facilitate
targeting.
Subsequently,
owing
to
excellent
free
radical‐scavenging
capacity,
PDA‐Mem@M
attenuate
brain
inflammatory
microenvironment.
After
on‐demand
release
from
nanoparticles,
memantine
increases
expression
brain‐derived
neurotrophic
factors
reverses
loss
synaptic
dendritic
spines.
Further,
vivo
studies
demonstrate
that
effectively
alleviate
depression‐like
behaviors
greater
extent
than
or
polydopamine
(PDA)
monotherapy.
This
strategy,
with
satisfactory
biosafety
strong
anti‐inflammatory
plasticity
restoration
effects,
conducive
advances
depression
therapy.
Lipids in Health and Disease,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: Feb. 28, 2025
Various
research
in
the
past
has
indicated
that
NHHR,
which
represents
ratio
of
non-high-density
lipoprotein
cholesterol
(non-HDL-C)
to
high-density
(HDL-C),
and
body
mass
index
(BMI)
each
act
independently
as
contributors
depression
risk.
Nonetheless,
studies
exploring
combination
NHHR
with
BMI
relation
are
limited.
Consequently,
central
aim
this
study
is
investigating
joint
interactive
effects
on
risk,
well
mediating
role
NHHR.
Encompassing
participants
aged
20
years
or
over,
incorporated
a
total
39,704
individuals
from
National
Health
Nutrition
Examination
Survey
(NHANES),
covered
period
2005
2023.
To
analyze
impact
its
depression,
our
analytical
approach
included
multivariate
logistic
regression,
restricted
cubic
spline
modeling,
interaction
testing
subgroup
analyses.
Additionally,
we
studied
BMI.
Finally,
applied
four-way
decomposition
analysis
method
examine
interactions
within
aforementioned
relationships.
Among
all
study,
prevalence
depressive
disorder
(Patient
Questionnaire-9
score
≥
10)
was
9.2%.
Both
were
associated
remained
significant
even
after
full
adjustment
for
covariates
[NHHR,
OR
(95%
CI):
1.07
(1.04–1.09);
BMI,
1.02
(1.02–1.03)].
Compared
reference
group,
CI)
highest
groups
their
product
term
NHHR-BMI
1.41
(1.24–1.61),
1.35
(1.18–1.54),
1.59
(1.37–1.84),
respectively.
Participants
fourth
quartile
exceeding
30
kg/m²,
had
higher
risk
compared
other
first
below
25
kg/m²
[OR
1.64
(1.34-2.00)].
Results
analyses
played
association
between
effect
accounting
17.6%.
Similarly,
also
mediated
11.0%
PHQ-9
score.
However,
no
related
found
general
population.
After
stratifying
by
gender,
it
statistically
males.
Depression
linked
both
depression.
Notably,
there
non-negligible
male
participants.
considering
individually,
when
combined
terms
two
quartiles.
These
findings
suggest
assessment
these
indicators
may
help
deepen
understanding
evaluation
enhance
accuracy
stratification,
worthy
further
research.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(1), P. 184 - 184
Published: Jan. 15, 2024
Perimenopausal
depression,
occurring
shortly
before
or
after
menopause,
is
characterized
by
symptoms
such
as
emotional
anxiety,
and
stress,
often
accompanied
endocrine
dysfunction,
particularly
hypogonadism
senescence.
Current
treatments
for
perimenopausal
depression
primarily
provide
symptomatic
relief
but
come
with
undesirable
side
effects.
The
development
of
agents
targeting
the
specific
pathologies
has
been
relatively
slow.
erratic
fluctuations
in
estrogen
progesterone
levels
during
stage
expose
women
to
risk
developing
perimenopausal-associated
depression.
These
hormonal
changes
trigger
production
proinflammatory
mediators
induce
oxidative
leading
progressive
neuronal
damage.
This
review
serves
a
comprehensive
overview
underlying
mechanisms
contributing
It
aims
shed
light
on
complex
relationship
between
hormones,
neurotransmitters,
brain-derived
neurotrophic
factors,
chronic
inflammation,
By
summarizing
intricate
interplay
fluctuations,
neurotransmitter
activity,
this
stimulate
further
research
field.
hope
that
an
increased
understanding
these
will
pave
way
more
effective
therapeutic
targets,
ultimately
reducing
menopausal
betterment
psychological
wellbeing.
Diabetes Obesity and Metabolism,
Journal Year:
2024,
Volume and Issue:
26(8), P. 3031 - 3044
Published: May 27, 2024
Abstract
Depression
is
a
mood
disorder
that
may
increase
risk
for
the
development
of
insulin
resistance
(IR)
and
type
2
diabetes
(T2D),
vice
versa.
However,
mechanistic
pathway
linking
depression
T2D
not
fully
elucidated.
The
aim
this
narrative
review,
therefore,
was
to
discuss
possible
link
between
T2D.
coexistence
twice
as
great
compared
occurrence
either
condition
independently.
Hyperglycaemia
dyslipidaemia
promote
incidence
by
enhancing
inflammation
reducing
brain
serotonin
(5‐hydroxytryptamine
[5HT]).
Dysregulation
signalling
in
impairs
5HT
signalling,
leading
depression.
Furthermore,
associated
with
hyperglycaemia
poor
glycaemic
control.
Psychological
stress
In
conclusion,
could
be
potential
factor
through
induction
inflammatory
reactions
oxidative
affect
neurotransmission.
addition,
chronic
induce
dysregulation
hypothalamic–pituitary–adrenal
axis
circulating
cortisol
levels,
which
triggers
IR
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(10), P. 1256 - 1256
Published: Oct. 17, 2024
Environmental
pollution
continues
to
increase
with
industrial
development
and
has
become
a
threat
human
health.
Atmospheric
particulate
matter
(PM)
was
designated
as
Group
1
carcinogen
by
the
International
Agency
for
Research
on
Cancer
in
2013
is
an
emerging
global
environmental
risk
factor
that
major
cause
of
death
related
cardiovascular
respiratory
diseases.
PM
complex
composed
highly
reactive
organic
matter,
chemicals,
metal
components,
which
mainly
excessive
production
oxygen
species
(ROS)
can
lead
DNA
cell
damage,
endoplasmic
reticulum
stress,
inflammatory
responses,
atherosclerosis,
airway
remodeling,
contributing
increased
susceptibility
exacerbation
various
diseases
infections.
effects
health
depending
particle
size,
physical
chemical
characteristics,
source,
exposure
period.
smaller
than
5
μm
penetrate
accumulate
alveoli
circulatory
system,
causing
harmful
skin,
brain.
In
this
review,
we
describe
relationship
mechanism
ROS-mediated
oxidative
responses
caused
organs,
well
comprehensively
discuss
harmfulness
PM.